105
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

, , , , , , & show all
Pages 151-162 | Published online: 11 Jul 2016

References

  • MajidSSalihMWasayaRJafriWPredictors of gastrointestinal lesions on endoscopy in iron deficiency anemia without gastrointestinal symptomsBMC Gastroenterol200885218992171
  • NivEElisAZissinRNaftaliTNovisBLishnerMIron deficiency anemia in patients without gastrointestinal symptoms – a prospective studyFam Pract2005221586115644385
  • CarterDLeviGTzurDNovisBAvidanBPrevalence and predictive factors for gastrointestinal pathology in young men evaluated for iron deficiency anemiaDig Dis Sci20135851299130523192647
  • LiuKKaffesAJIron deficiency anaemia: a review of diagnosis, investigation and managementEur J Gastroenterol Hepatol201224210911622157204
  • McCannJCAmesBNAn overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral functionAm J Clin Nutr200785493194517413089
  • BangSMLeeJOKimYJAnemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA)Ann Hematol2013921596522956182
  • AndoKMoritaSHigashiTHealth-related quality of life among Japanese women with iron-deficiency anemiaQual Life Res200615101559156316826432
  • BartonJCBartonEHBertoliLFGothardCHSherrerJSIntravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementationAm J Med20001091273210936475
  • KulniggSGascheCSystematic review: managing anaemia in Crohn’s diseaseAliment Pharmacol Ther20062411–121507152317206940
  • SchroderOMickischOSeidlerUIntravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease–a randomized, controlled, open-label, multicenter studyAm J Gastroenterol2005100112503250916279906
  • Van AsscheGDignassABokemeyerBEuropean Crohn’s and Colitis OrganisationSecond European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situationsJ Crohns Colitis20137113323040453
  • AMAG Pharmaceuticals IncFeraheme (ferumoxytol) Injection [Prescribing Information]Waltham, MAAMAG Pharmaceuticals, Inc2015
  • JahnMRAndreasenHBFuttererSA comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implicationsEur J Pharm Biopharm201178348049121439379
  • Vadhan-RajSStraussWFordDEfficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironAm J Hematol201489171223983177
  • YellenSBCellaDFWebsterKBlendowskiCKaplanEMeasuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJ Pain Symptom Manage199713263749095563
  • WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
  • PatrickDLGagnonDDZagariMJMathijsRSweetenhamJEpoetin Alfa Study GroupAssessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfaEur J Cancer200339333534512565986
  • CellaDEtonDTLaiJSPetermanAHMerkelDECombining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scalesJ Pain Symptom Manage200224654756112551804
  • CellaDLaiJSChangCHPetermanASlavinMFatigue in cancer patients compared with fatigue in the general United States populationCancer200294252853811900238
  • NormanGRSloanJAWyrwichKWInterpretation of changes in health-related quality of life: the remarkable universality of half a standard deviationMed Care200341558259212719681
  • HetzelDStraussWBernardKLiZUrbonieneAAllenLFA phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyAm J Hematol201489664665024639149
  • KoutroubakisIEOustamanolakisPKarakoidasCMantzarisGJKouroumalisEASafety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel diseaseDig Dis Sci20105582327233119834803
  • KhalilAGoodhandJRWahedMYeungJAliFRRamptonDSEfficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practiceEur J Gastroenterol Hepatol201123111029103521857526
  • KulniggSStoinovSSimanenkovVA novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trialAm J Gastroenterol200810351182119218371137
  • LindgrenSWikmanOBefritsRIntravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre studyScand J Gastroenterol200944783884519330567
  • HetzelDStraussWBernardKLiJAllenLIV iron treatment of iron deficiency anaemia with ferumoxytol in patients with gastrointestinal disorders unable to take oral iron: a randomized controlled trial versus iron sucrose [Abstract P485]J Crohns Colitis20137S204
  • StraussWDahlNVVadhan-RajSEffects of IV iron treatment with ferumoxytol on health related quality of life of patients with iron deficiency anemiaJ Commun Support OncolIn Press2016
  • GlaspyJBukowskiRSteinbergDTaylorCTchekmedyianSVadhan-RajSImpact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study GroupJ Clin Oncol1997153121812349060566